At PhRMA, we often talk about the complexity of developing innovative medicines. Critical to researching new medicines is a workforce that combines sheer brainpower with a level of perseverance unmatched in other industries.
To attract and maintain a strong workforce, we are proud to recognize diversity in the workplace, especially our LGBT colleagues. With today marking the final day of Lesbian, Gay, Bisexual, and Transgender (LGBT) Pride Month, PhRMA is proud to celebrate the diversity of our own and member companies’ LGBT employees by recognizing their important contributions to the drug discovery process.
Diversity in the biopharmaceutical industry is vital as it facilitates openness to new ideas, collaboration and an appreciation of each and every employee’s unique contributions. As a member of the LGBT community myself, I see firsthand how our companies efforts to support inclusion are helping pave the way to new ideas and approaches to researching innovative medicines for patients.
As we close our LGBT PRIDE Month, we celebrate the importance of diversity in each and every employee and patients we serve.
Andrew Powaleny Andrew Powaleny is Director of Public Affairs at PhRMA. Before joining PhRMA in 2015, he worked at the House Energy and Commerce Committee and later as a communications consultant. Andrew came to Washington, D.C. via Connecticut and proudly runs with the DC Front Runners and serves as its co-race director. He is also a member of the National Lesbian Gay Journalists Association and a proud alum of The Fund for American Studies. He’s passionate about scientific innovation, especially for mental illness, and his heroes are the men and women of America’s biopharmaceutical research companies.